Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
The Korean Journal of Internal Medicine ; : 856-864, 2015.
Artículo en Inglés | WPRIM | ID: wpr-195233

RESUMEN

BACKGROUND/AIMS: To prevent hypocalcemia after parathyroidectomy (PTX), parenteral calcium is required in addition to oral calcitriol and calcium. After switching to oral calcium, patients can be discharged from the hospital. The aim of this study was to analyze the clinical characteristics and outcomes of PTX performed at a single Korean center and to investigate the associated laboratory factors used to analyze the total amount of postoperative calcium required. METHODS: We enrolled 91 hemodialysis patients undergoing PTX from November 2003 to December 2011. We collected clinical and laboratory data preoperatively, 12 and 48 hours postoperatively, at discharge, and 3 and 6 months postoperatively. RESULTS: In total, 59 patients underwent PTX with autotransplantation (AT), 6 underwent total PTX without AT, 11 underwent subtotal PTX, and 15 underwent limited PTX. Total PTX without AT showed the lowest recurrence rate. At all postoperative time points, the mean levels of serum calcium, phosphorus, and intact parathyroid hormone (iPTH) decreased significantly, compared with preoperative levels; however, alkaline phosphatase (ALP) increased significantly from 48 hours postoperatively to discharge (p < 0.001). On multiple linear regression analysis, the total amount of injected calcium during hospitalization showed a significant correlation with preoperative ALP (p < 0.001), preoperative iPTH (p = 0.037), and Deltaphosphorus at 48 hours (p < 0.001). We developed an equation for estimating the total calcium requirement after PTX. CONCLUSIONS: Preoperative ALP, preoperative iPTH, and Deltaphosphorus at 48 hours may be significant factors in estimating the postoperative calcium requirement. The formula for postoperative calcium requirement after PTX may help to predict the duration of postoperative hospitalization.


Asunto(s)
Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Adulto Joven , Administración Intravenosa , Administración Oral , Biomarcadores/sangre , Calcio/sangre , Carbonato de Calcio/administración & dosificación , Compuestos de Calcio/administración & dosificación , Gluconato de Calcio/administración & dosificación , Técnicas de Apoyo para la Decisión , Suplementos Dietéticos , Hiperparatiroidismo Secundario/sangre , Hipocalcemia/diagnóstico , Lactatos/administración & dosificación , Modelos Lineales , Modelos Biológicos , Análisis Multivariante , Hormona Paratiroidea/sangre , Paratiroidectomía/efectos adversos , Fósforo/sangre , Recurrencia , República de Corea , Estudios Retrospectivos , Factores de Riesgo , Factores de Tiempo , Resultado del Tratamiento
2.
Kidney Research and Clinical Practice ; : 20-27, 2015.
Artículo en Inglés | WPRIM | ID: wpr-88023

RESUMEN

BACKGROUND: Anemia is a major risk factor that contributes to mortality in patients with chronic kidney disease. There is controversy over the optimal hemoglobin (Hb) target in these patients. This study investigated the association between Hb level and mortality in a cohort of hemodialysis (HD) patients in Korea. METHODS: This study was a multicenter prospective observational study of maintenance HD patients that was performed for 5 years in western Seoul, Korea. Three hundred and sixty-two participants were enrolled. Laboratory values and mortality were accessed every 6 months. Repeated measures of laboratory values in each interval were averaged to obtain one semiannual mean value. The Hb values were divided into six groups: (1) Hb or =13 g/dL. We analyzed the odds ratio for all-cause mortality, based on the Hb group, and adjusted for demographics and various laboratory values. Statistics were performed with SAS, version 9.1 software (SAS Institute Inc., Cary, NC, USA). RESULTS: Mortality odds ratios relative to the reference group (10-11 g/dL) in the fully adjusted model were 3.61 for or =13 g/dL (* indicates P<0.05). CONCLUSION: In this study, a Hb level of 10-11 g/dL was associated with the lowest mortality among the groups with Hb level<13 g/dL. Larger interventional trials are warranted to determine the optimal Hb target for Korean HD patients.


Asunto(s)
Humanos , Anemia , Estudios de Cohortes , Demografía , Corea (Geográfico) , Mortalidad , Estudio Observacional , Oportunidad Relativa , Estudios Prospectivos , Diálisis Renal , Insuficiencia Renal Crónica , Factores de Riesgo , Seúl
3.
Korean Journal of Gastrointestinal Endoscopy ; : 424-427, 2011.
Artículo en Coreano | WPRIM | ID: wpr-150381

RESUMEN

Neuroendocrine carcinomas mostly occur in the gastrointestinal tract, lung and pancreas. The gallbladder is an uncommon organ for a neuroendocrine carcinoma and it is difficult to diagnose before gallbladder surgery. Owing to its rare occurrence its natural course and treatment are not definitely established. A 71-year-old woman was hospitalized with intermittent abdominal pain and nausea. Abdominal computed tomography showed multiple masses of the gallbladder obstructing the biliary tract. From endoscopic ultrasonography we suspected carcinoma of the gallbladder that was infiltrating a common bile duct. A biopsy was taken using endoscopic retrograde cholangiopancreatography (ERCP) and the mass was diagnosed as a neuroendocrine carcinoma of the gallbladder. Here we report a case of a neuroendocrine carcinoma of the gallbladder confirmed by endoscopic biopsy, and provide a review of the literature.


Asunto(s)
Anciano , Femenino , Humanos , Dolor Abdominal , Sistema Biliar , Biopsia , Carcinoma Neuroendocrino , Colangiopancreatografia Retrógrada Endoscópica , Conducto Colédoco , Endoscopía , Endosonografía , Vesícula Biliar , Tracto Gastrointestinal , Pulmón , Náusea , Páncreas
4.
Infection and Chemotherapy ; : 359-362, 2011.
Artículo en Coreano | WPRIM | ID: wpr-39115

RESUMEN

Mycobacterium avium intracellulare complex (MAC) usually causes an opportunistic pulmonary infection in immunocompromised hosts who have underlying structural lung disease. Central nervous system infection due to MAC is very rare even in an immunocompromised host. Most previous reports of central nervous system infection due to MAC have been meningoencephalitis in patients infected with human immunodeficiency virus (HIV). Only four cases of brain abscess due to MAC have been reported worldwide. We report a case of brain abscess due to MAC in a non-HIV patient. Although drugs used for treatment of MAC have limited central nervous penetration, an azithromycin-based anti-tuberculous therapy after surgical drainage of the abscess showed improvement. To the best of our knowledge, this is the first reported case of MAC brain abscess in the Korean literature.


Asunto(s)
Humanos , Absceso , Absceso Encefálico , Infecciones del Sistema Nervioso Central , Drenaje , VIH , Huésped Inmunocomprometido , Enfermedades Pulmonares , Meningoencefalitis , Mycobacterium , Mycobacterium avium
5.
Experimental & Molecular Medicine ; : 196-207, 2008.
Artículo en Inglés | WPRIM | ID: wpr-52235

RESUMEN

We made fusion protein of fastatin and FIII 9-10, termed tetra-cell adhesion molecule (T-CAM) that can interact simultaneously with alphavbeta3 and alpha5beta1 integrins, both playing important roles in tumor angiogenesis. T-CAM can serve as a cell adhesion substrate mediating adhesion and migration of endothelial cells in alphavbeta3 and alpha5beta1 integrin-dependent manner. T-CAM showed pronounced anti-angiogenic activities such as inhibition of endothelial cell tube formation, endothelial cell proliferation, and induction of endothelial cell apoptosis. T-CAM also inhibited angiogenesis and tumor growth in mouse xenograft model. The anti-angiogenic and anti-tumoral activity of molecule like fastatin could be improved by fusing it with integrin-recognizing cell adhesion domain from other distinct proteins. The strategy of combining two distinct anti-angiogenic molecules or cell adhesion domains could facilitate designing improved anticancer agent of therapeutic value.


Asunto(s)
Animales , Humanos , Masculino , Ratones , Inhibidores de la Angiogénesis/química , Antineoplásicos/química , Secuencia de Bases , Benzocaína/química , Línea Celular Tumoral , Movimiento Celular , Proliferación Celular , Células Cultivadas , Cloranfenicol/química , Cartilla de ADN , Combinación de Medicamentos , Factor VIII/química , Integrina alfa5beta1/fisiología , Integrina alfaVbeta3/fisiología , Ratones Endogámicos BALB C , Nitrofurazona/química , Proteínas Recombinantes de Fusión/química
6.
Experimental & Molecular Medicine ; : 663-672, 2007.
Artículo en Inglés | WPRIM | ID: wpr-170420

RESUMEN

An extracellular matrix protein plays an important role in skin wound healing. In the present study, we engineered a recombinant protein encompassing the 9th and 10th type III domains of fibronectin, and 4th FAS1 domain of beta ig-h3. This recombinant protein, in total, harbors four known-cell adhesion motifs for integrins: Pro-His-Ser-Arg-Asn (PHSRN) and Arg-Gly-Asp (RGD) in 9th and 10th type III domains of fibronectin, respectively, and Glu-Pro-Asp-Ile-Met (EPDIM) and Try-His (YH) in 4th FAS1 domain of big-h3, were designated to tetra-cell adhesion motifs (T-CAM). In vitro studies showed T-CAM supporting adhesion, migration and proliferation of different cell types including keratinocytes and fibroblasts. In an animal model of full-thickness skin wound, T-CAM exhibited excellent wound healing effects, superior to both 4th FAS1 domain of beta ig-h3 or 9th and 10th type III domains of fibronectin. Based on these results, T-CAM can be applied where enhancement of cell adhesion, migration and proliferation are desired, and it could be developed into novel wound healing drug.


Asunto(s)
Animales , Humanos , Ratones , Conejos , Secuencias de Aminoácidos , Adhesión Celular/efectos de los fármacos , Línea Celular , Movimiento Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Proteínas de la Matriz Extracelular/química , Fibroblastos/citología , Fibronectinas/química , Queratinocitos/citología , Células 3T3 NIH , Proteínas Recombinantes de Fusión/química , Factor de Crecimiento Transformador beta/química , Cicatrización de Heridas/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA